NCT01081509
Completed
Not Applicable
Survey and Follow-up of the Treatment Adherence and Medication Habits of Early Breast Cancer Patients on Adjuvant Hormonal Therapy With the Aromatase Inhibitor Arimidex
ConditionsBreast Cancer
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Breast Cancer
- Sponsor
- AstraZeneca
- Enrollment
- 1077
- Locations
- 1
- Primary Endpoint
- Percent of patients remaining adherent to therapy with Arimidex
- Status
- Completed
- Last Updated
- 14 years ago
Overview
Brief Summary
The aim of this study is to assess the patient's perception about and willingness to take his or her medication and the influencing factors interfering with taking medication.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Early breast cancer
- •Post menopausal
- •Adjuvant hormonal Arimidex therapy
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Percent of patients remaining adherent to therapy with Arimidex
Time Frame: Every 3 months
Secondary Outcomes
- Questionnaire for factors influencing adherence(Every 3 months)
Study Sites (1)
Loading locations...
Similar Trials
Terminated
Not Applicable
Evaluation of the Adherence and the Patient Acceptability of Zomacton® Treatment With the Zomajet® Vision X DeviceGrowth Hormone DeficiencyTurner's SyndromeNCT02018172Ferring Pharmaceuticals3
Completed
Not Applicable
Assessment of adherenCe tO Medical theraРy and Its infLuence on Long-term Outcomes In pAtieNts With Heart FailureHeart FailureNCT04262583National Research Center for Preventive Medicine72
Completed
Not Applicable
ADHEPTA Study: Adherence Questionnaire in Hepatitis CHepatitis C, ChronicHIV InfectionNCT00998621Fundacion IMIM1,120
Recruiting
Not Applicable
A Qualitative Study on Treatment Adherence in Patients With Metastatic Breast CancerMetastatic Breast CancerNCT06343181European Institute of Oncology20
Terminated
Not Applicable
Study of Diroximel Fumarate in the Real-World SettingRelapsing Forms of MSNCT04746976Biogen75